Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Duval

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Pharmaceutical Research|January 14, 2003
Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment modelVincent Duval, Mats O Karlsson
Frontiers in Cardiovascular Medicine|October 19, 2018
Cardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac RepairIngrid Gomez, Vincent Duval, Jean-Sébastien Silvestre
Medecine Sciences : M/S|October 11, 2022
[Deleterious role of spleen marginal zone B lymphocytes in ventricular remodeling after myocardial infarction]Vincent Duval, Paul Alayrac, Ziad Mallat, et al.
Frontiers in Endocrinology|July 18, 2022
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular DiseasesVincent Duval, Paul Alayrac, Jean-Sébastien Silvestre, et al.
Clinical Pharmacology and Therapeutics|May 19, 2022
A Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or BSylvie Retout, Stefan De Buck, Sébastien Jolivet, et al.
Journal of Clinical Pharmacology|February 18, 2010
Impact of target-mediated drug disposition on Linagliptin pharmacokinetics and DPP-4 inhibition in type 2 diabetic patientsSilke Retlich, Vincent Duval, Ulrike Graefe-Mody, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 13, 2005
Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trialMarylore Chenel, Kayode Ogungbenro, Vincent Duval, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 13, 2002
Physiologically based model of acute ischemic strokeVincent Duval, Sylvie Chabaud, Pascal Girard, et al.
Clinical Pharmacokinetics|February 1, 2015
Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes MellitusSilke Retlich, Vincent Duval, Ulrike Graefe-Mody, et al.
Journal of Clinical Pharmacology|July 18, 2015
A phase-1, open-label, single-dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairmentDenes Csonka, Katharine Hazell, Edward Waldron, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Pharmaceutical Research|January 14, 2003
Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment modelVincent Duval, Mats O Karlsson
Frontiers in Cardiovascular Medicine|October 19, 2018
Cardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac RepairIngrid Gomez, Vincent Duval, Jean-Sébastien Silvestre
Medecine Sciences : M/S|October 11, 2022
[Deleterious role of spleen marginal zone B lymphocytes in ventricular remodeling after myocardial infarction]Vincent Duval, Paul Alayrac, Ziad Mallat, et al.
Frontiers in Endocrinology|July 18, 2022
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular DiseasesVincent Duval, Paul Alayrac, Jean-Sébastien Silvestre, et al.
Clinical Pharmacology and Therapeutics|May 19, 2022
A Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or BSylvie Retout, Stefan De Buck, Sébastien Jolivet, et al.
Journal of Clinical Pharmacology|February 18, 2010
Impact of target-mediated drug disposition on Linagliptin pharmacokinetics and DPP-4 inhibition in type 2 diabetic patientsSilke Retlich, Vincent Duval, Ulrike Graefe-Mody, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 13, 2005
Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trialMarylore Chenel, Kayode Ogungbenro, Vincent Duval, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 13, 2002
Physiologically based model of acute ischemic strokeVincent Duval, Sylvie Chabaud, Pascal Girard, et al.
Clinical Pharmacokinetics|February 1, 2015
Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes MellitusSilke Retlich, Vincent Duval, Ulrike Graefe-Mody, et al.
Journal of Clinical Pharmacology|July 18, 2015
A phase-1, open-label, single-dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairmentDenes Csonka, Katharine Hazell, Edward Waldron, et al.
Pageof 3